InsiderClue
Stocks · Health care · Services-Medical Laboratories

Labcorp

LH Clue Score34
United States Fiscal year ends December CIK 0000920148 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

61
Insider
Date
Role
Action
Shares
Price
Amount
Peter J Wilkinson
3 Aug 2026
SVP, Chief Accounting Officer
Sold after exercise
1,338
$309.23
$413.75K
Peter J Wilkinson
3 Aug 2026
SVP, Chief Accounting Officer
Sold after exercise
82
$309.22
$25.36K
Adam H Schechter
11 Feb 2026
President & CEO
Sold after exercise
5,273
$284.38
$1.50M
der Vaart Sandra D van
13 Aug 2025
EVP, Chief Legal Officer
Sold after exercise
3,903
$271.42
$1.06M
Mark S Schroeder
28 Feb 2025
EVP, Pres Diagnostics & COO
Sold after exercise
5,339
$249.23
$1.33M
Peter J Wilkinson
18 Feb 2025
SVP, Chief Accounting Officer
Sold after exercise
1,413
$246.10
$347.74K
Adam H Schechter
11 Feb 2025
President & CEO
Sold after exercise
6,121
$244.62
$1.50M
Glenn A Eisenberg
2 Dec 2024
Executive Vice President
Sold after exercise
11,711
$240.43
$2.82M
Amy B. Summy
22 Nov 2024
EVP, Chief Marketing Officer
Sold after exercise
3,672
$238.91
$877.14K
Mark S Schroeder
7 Mar 2024
EVP, Pres Diagnostics & COO
Sold after exercise
5,048
$218.45
$1.10M
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
1,553
$217.98
$338.53K
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
6,665
$217.52
$1.45M
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
7,907
$215.68
$1.71M
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
18,379
$215.37
$3.96M
Paul R Kirchgraber
19 May 2023
CEO, Covance Drug Development
Sold after exercise
4,300
$216.91
$932.71K
Mark S Schroeder
18 May 2023
EVP, Pres Diagnostics & COO
Sold after exercise
1,500
$216.77
$325.16K
Paul R Kirchgraber
21 Feb 2023
CEO, Covance Drug Development
Sold after exercise
8,000
$250.58
$2.00M
Glenn A Eisenberg
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
1,500
$254.88
$382.32K
Glenn A Eisenberg
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
19,338
$254.26
$4.92M
Glenn A Eisenberg
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
11,262
$253.27
$2.85M
Peter J Wilkinson
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
10
$258.71
$2.59K
Peter J Wilkinson
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
757
$258.60
$195.76K
Peter J Wilkinson
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
1,809
$258.31
$467.29K
der Vaart Sandra D van
15 Sep 2021
EVP, Chief Legal Officer
Sold after exercise
4,500
$296.78
$1.34M
der Vaart Sandra D van
7 Jun 2021
EVP, Chief Legal Officer
Sold after exercise
4,500
$266.56
$1.20M
Jean-Luc Belingard
3 May 2021
Director
Sold after exercise
2,600
$269.16
$699.80K
Peter J Wilkinson
18 Feb 2021
SVP, Chief Accounting Officer
Sold after exercise
2,317
$241.51
$559.59K
R Sanders Williams
8 Jul 2020
Director
Sold after exercise
1,300
$173.12
$225.06K
Jean-Luc Belingard
19 Feb 2020
Director
Sold after exercise
26,479
$189.76
$5.02M
Kerrii B Anderson
23 Sep 2019
Director
Sold after exercise
2,600
$171.85
$446.81K
Lisa J Uthgenannt
4 Sep 2019
Chief Human Resources Officer
Sold after exercise
2,466
$168.59
$415.74K
Kerrii B Anderson
20 Jun 2019
Director
Sold after exercise
3,100
$170.00
$527.00K
Robert E Mittelstaedt Jr
3 May 2019
Director
Sold after exercise
3,700
$166.30
$615.31K
Jean-Luc Belingard
12 Feb 2019
Director
Sold after exercise
3,700
$146.06
$540.41K
Kerrii B Anderson
5 Nov 2018
Director
Sold after exercise
3,700
$163.29
$604.16K
Edward T Dodson
6 Jun 2018
Principal Accounting Officer
Sold after exercise
13,000
$183.35
$2.38M
David P King
23 May 2018
President & CEO
Sold after exercise
5,400
$176.13
$951.09K
David P King
23 May 2018
President & CEO
Sold after exercise
44,566
$175.27
$7.81M
David P King
23 Apr 2018
President & CEO
Sold after exercise
21,200
$166.37
$3.53M
David P King
23 Apr 2018
President & CEO
Sold after exercise
28,767
$165.94
$4.77M
David P King
23 Mar 2018
President & CEO
Sold after exercise
1,700
$166.38
$282.84K
David P King
23 Mar 2018
President & CEO
Sold after exercise
10,313
$165.39
$1.71M
David P King
23 Mar 2018
President & CEO
Sold after exercise
36,265
$164.55
$5.97M
David P King
23 Mar 2018
President & CEO
Sold after exercise
1,689
$163.58
$276.29K
Kerrii B Anderson
9 Feb 2018
Director
Sold after exercise
3,300
$166.10
$548.12K
David P King
6 Sep 2017
President & CEO
Sold after exercise
7,500
$157.34
$1.18M
David P King
6 Sep 2017
President & CEO
Sold after exercise
37,187
$156.77
$5.83M
David P King
5 Sep 2017
President & CEO
Sold after exercise
132,713
$157.06
$20.84M
F Samuel Eberts III
25 Aug 2017
Chief Legal Officer, Secretary
Sold after exercise
31,500
$155.22
$4.89M
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
11
$156.92
$1.73K
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
8
$156.91
$1.26K
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
2,881
$156.90
$452.02K
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
200
$156.68
$31.34K
Jean-Luc Belingard
9 May 2017
Director
Sold after exercise
992
$142.19
$141.05K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
367
$142.72
$52.38K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
100
$142.70
$14.27K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
2,000
$142.69
$285.38K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
2,633
$142.69
$375.69K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
200
$142.68
$28.54K
Kerrii B Anderson
23 Feb 2017
Director
Sold after exercise
1,000
$140.00
$140.00K
Kerrii B Anderson
23 Feb 2017
Director
Sold after exercise
992
$140.00
$138.88K
Show all 221 transactions →

What was left out

Form 4 filings counted 735
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 61
Sales at will 115
Transactions with no price 0
Shares from compensation/vesting 2,553,569
Sales filed before the plan box existed 84
History held since 4 Oct 2006